[HTML][HTML] The anatomy of pain and suffering in the brain and its clinical implications

D De Ridder, D Adhia, S Vanneste - Neuroscience & Biobehavioral …, 2021 - Elsevier
Pain is an unpleasant sensory and emotional experience associated with actual or potential
tissue damage. Chronic pain, with a prevalence of 20–30% is the major cause of human …

Postoperative cognitive dysfunction: minding the gaps in our knowledge of a common postoperative complication in the elderly

M Berger, JW Nadler, J Browndyke… - …, 2015 - anesthesiology.theclinics.com
Ever since Bedford's 1 seminal Lancet case series in 1955, we have known that
perioperative care is sometimes followed by significant cognitive dysfunction. Although the …

Co-morbidity of PTSD and immune system dysfunction: opportunities for treatment

GN Neigh, FF Ali - Current opinion in pharmacology, 2016 - Elsevier
Highlights•PTSD co-occurs with somatic diseases.•PTSD is commonly associated with
neuroendocrine and immune dysfunction.•Targeting neuroendocrine and immune …

[HTML][HTML] Ketamine for the treatment of refractory status epilepticus

Y Fang, X Wang - Seizure, 2015 - Elsevier
Status epilepticus (SE) is an acute and severe illness of the central nervous system, and
prolonged SE can lead to brain damage and even death. Ketamine is a noncompetitive …

[HTML][HTML] miR-98-5p plays a critical role in depression and antidepressant effect of ketamine

C Huang, Y Wang, Z Wu, J Xu, L Zhou, D Wang… - Translational …, 2021 - nature.com
Ketamine has been demonstrated to be a rapid-onset and long-lasting antidepressant, but
its underlying molecular mechanisms remain unclear. Recent studies have emerged …

Repurposing of drugs–the ketamine story

J Das - Journal of Medicinal Chemistry, 2020 - ACS Publications
An intranasal formulation of esketamine, the S enantiomer of ketamine, in conjunction with
an oral antidepressant, has been approved by the FDA for treating treatment-resistant major …

Ketamine: an update on cellular and subcellular mechanisms with implications for clinical practice

GJ Iacobucci, O Visnjevac, L Pourafkari… - Pain …, 2017 - search.proquest.com
BACKGROUND: Ketamine is one of the oldest hypnotic agents used to provide an
anesthetic agent with analgesic properties and minimal suppressive effects on respiration …

Drug pharmacokinetics determined by real‐time analysis of mouse breath

X Li, P Martinez‐Lozano Sinues… - Angewandte Chemie …, 2015 - Wiley Online Library
Noninvasive, real‐time pharmacokinetic (PK) monitoring of ketamine, propofol, and valproic
acid, and their metabolites was achieved in mice, using secondary electrospray ionization …

Drug repurposing may generate novel approaches to treating depression

ME Ebada - Journal of Pharmacy and Pharmacology, 2017 - academic.oup.com
Objectives The breakthrough advancements in scientific medical research have greatly
improved our understanding of the pathogenesis of depression, encouraging drug …

Ketamine‐an update on its clinical uses and abuses

J Xu, H Lei - CNS neuroscience & therapeutics, 2014 - Wiley Online Library
This review highlights the recent clinical research that supports the therapeutic utility of
ketamine as a multifaceted drug. After long‐term use as a dissociative anesthetic, it has re …